Early research suggested the peptide might play a role in: Gastrointestinal tissue repair Protection against gastric ulcers Anti-inflammatory activity in intestinal tissue Angiogenesis (formation of new blood vessels) Because of these findings, BPC-157 has been explored in experimental models of: Gastric ulcers Intestinal injury Inflammatory bowel disease Tissue regeneration It has also gained attention online for broader claims related to injury healing and systemic health
Pinealon protects the rat offspring from prenatal hyperhomocysteinemia
16 Yohimbine may also cause irritability and tremor
Related peptides View all Adamax 10mg Nootropic research peptide Research use only BPC-157 + TB-500 10mg Tissue repair research blend Research use only Bacteriostatic Water 10ml Sterile diluent for reconstitution Research use only GHK-Cu 100mg Collagen synthesis research peptide Research use only
Tesamorelin (elimination half-life approximately 8 minutes after subcutaneous administration, once-daily dosing, FDA-approved, Phase 3 visceral fat data) and CJC-1295 (DAC-modified, approximately 8-day half-life, once-weekly dosing, no approved indication) represent fundamentally different engineering approaches to GHRH agonism [5]
They applied that information to study the effects of synthetic peptide bioregulators, Epithalon, and Vilon on the apoptosis of lymphocytes
